Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.
This content is provided by Matthew Berger
Matthew D. Berger is a partner in the Corporate & Financial Services Department and Chair of the IP, Technology & Commercial Transactions Practice, focusing on complex technology transactions and intellectual property counseling and advice. He advises clients generally in high technology industries such as the semiconductor, life sciences, and alternative energy industries. Matthew has extensive experience in negotiating and drafting agreements for the development, licensing, production, supply, and support of semiconductors and other hardware; software and data; pharmaceutical, biotechnology, and medical devices and systems; and multimedia and entertainment products and content. He has negotiated agreements for the protection and transfer of copyrights, trademarks, patents, trade secrets, and other intellectual property, and has litigated copyright, trademark, patent, trade secret, royalty, and domain name claims and disputes. In addition, Matthew represents technology, life sciences, and media and entertainment companies in financings, mergers and acquisitions, strategic alliances, and joint ventures, and other corporate structuring matters. He also represents emerging technology companies and ventures in entity formation, and is experienced in structuring and negotiating angel and venture financing.
JD, University of California, Hastings College of the Law, 1992. BA, Cornell University, 1987. See: https://www.willkie.com/professionals/b/berger-matthew